Allied Market Research
Loading...
0
New
New
2021
Clinical Nutrition Market

Clinical Nutrition Market by Route of Administration (Oral, Enteral, and Parental), Application (Cancer, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders and Others), and End User (Pediatric, Adult, and Geriatric): Global Opportunity Analysis and Industry Forecast, 2021-2028

A00717
Pages: 205
May 2021 | 8431 Views
   
Author(s) : Surabhi Pandey , Onkar Sumant
Tables: 114
Charts: 38
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Clinical Nutrition Market

Request Now !

Clinical Nutrition Market Overview:

The global clinical nutrition market size was valued at $32,495.97 million in 2020, and is projected to reach $51,128.26 million by 2028, registering a CAGR of 6.1% from 2021 to 2028.

Enteral nutrition segment is expected to witness growth owing to its wide application in COVID 19 treatment.

Clinical nutrition product is a type of pharmaceutical product that helps to keep a patient healthy. It helps to improve the metabolic system by providing adequate supplements such as minerals, vitamins, and others. Clinical nutrition diagnosis and treat diseases that affect the intake, intestinal absorption, and metabolism of constituents of the diet, and help promote health through prevention of diet-related diseases. It works in both acute and ambulatory care settings, which includes cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs. 

Global Clinical Nutrition Market, 2020-2028

Get more information on this report : Request Sample Pages

The COVID-19 pandemic is expected to have a strong influence on the clinical nutrition products market, as the demand for nutritional management, particularly among children and older population, continues to witness consistent growth. The demand for clinical nutrition products amid the ongoing COVID-19 crisis is on the rise, as consumers are seeking various immunity-boosting alternatives to prevent being infected from the novel coronavirus. The onset of pandemic, older people and patients are at the risk of malnutrition. The infection also causes a serve lack of appetite, along with other symptoms such as anosmia dysgeusia, or diarrhea, both of which raise the risk of disease related malnutrition. Acute malnutrition caused by COVID-19 infection led to increase in loss of muscle mass and a deterioration of immune defenses.

Moreover, some of the medication used in treating malnutrition can exacerbate the effects caused by Covid-19, which can enhance the demand for the clinical nutrition market. Hence, the clinical nutrition market is negatively impacted by the COVID-19 pandemic.

The growth of the global clinical nutrition market is majorly driven by rise in prevalence of metabolic disorders, high spending on healthcare, and the rise of the middle class in emerging economies. Further, the growing number of elderly population and development of clinical nutrition products specific to ageing population is expected to thrive the market growth. However, certain restraints such as lack of awareness for clinical medical nutrition and stringent regulations, are hampering the market growth for clinical nutrition. 

By route of administration, the clinical nutrition market is segmented into oral, Enteral and Parental. Further, by application, it is divided into cancer, neurological disorders, metabolic disorders, gastrointestinal disorders and others. By end user, it is segregated into pediatric, adults, and geriatric. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America clinical nutrition market accounted for the largest share in 2020 followed by Europe; however, the Asia-Pacific region is anticipated to grow with the highest CAGR 7.20% during the forecast period. 

Route of Administration segment review

By route of administration, the oral segment held the largest share in 2020 and is anticipated to maintain its dominance during the forecast period, owing to increase in malnourished patients who have malignancy, chronic disease, and/or anorexia and increase in incidences of chronic diseases such as cancer, gastrointestinal disorders and metabolic disorders provides lucrative growth opportunities for oral clinical nutrition market. Further, the enteral segment is estimated to be the fastest growing segment at a CAGR of 7.30% during the forecast period.

Clinical Nutrition Market
By Route of Administration

Your browser does not support the canvas element.

Oral Clinical Nutriton segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Application segment review

On the basis of application, the cancer segment is expected to register highest CAGR of 10.50% during the forecast period, owing to increase in number of people suffering from chronic conditions such as cancer and diabetes coupled with growing geriatric population base, is expected to drive the market over the forecast timeframe. Rising incidences of chronic diseases have stimulated growth in clinical nutrition prescriptions as patients suffering from such conditions are deprived of few essential nutrients. Moreover, increasing obese population due to unhealthy dietary habits as well as physical inactivity will propel the industry growth.

Clinical Nutrition Market
By Application

Your browser does not support the canvas element.

Cancer Segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Region segment review

By region, North America accounted for the largest share in 2020, and is anticipated to maintain its dominance from 2021 to 2028, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, as Governments of Asian countries are investing in the development of healthcare infrastructure.

Clinical Nutrition Market
By Region

2028
North America 
Europe
Asia-pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 7.20% during 2020-2028.

Get more information on this report : Request Sample Pages

Some of the key players operating in the global clinical nutrition market include Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Lonza Ltd, Nestlé S.A., and Hero Nutritionals Inc.

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current global clinical nutrition market trends from 2020 to 2028 to identify the prevailing opportunities along with the strategic assessment.
  • The clinical nutrition market forecast is studied from 2021 to 2028.
  • The market size and estimations are based on a comprehensive analysis of key developments in the clinical nutrition industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the clinical nutrition market.

Key Market Segments

By Route of Administration 

  • Oral
  • Enteral
  • Parenteral

By Application 

  • Cancer 
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders
  • Others 

By End User

  • Pediatric 
  • Adults 
  • Geriatric 

By Region 

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • South Africa
    • Saudi Arabia 
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key Findings

3.2.1.Top Investment Pockets

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Rise in incidence of chronic diseases and lifestyle associated disease
3.3.1.2.Increasing incidence of cancer and central nervous system (CNS) diseases
3.3.1.3.Surge in geriatric population across the globe

3.3.2.Restraint

3.3.2.1.Lack of awareness for clinical nutrition
3.3.2.2.Stringent regulations and poor reimbursement policies

3.3.3.Opportunities

3.3.3.1.Various growth opportunities in emerging economies

3.4.Impact of COVID-19 on Clinical Nutrition Market

CHAPTER 4:CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION

4.1.Overview

4.1.1.Market size and forecast

4.2.Oral

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Enteral

4.3.1.Key trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Parenteral

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:CLINICAL NUTRITION MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Cancer

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Neurological Diseases

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Gastrointestinal Disorders

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Metabolic Disorders

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

5.6.Others

5.6.1.Market size and forecast
5.6.2.Market analysis, by country

CHAPTER 6:CLINICAL NUTRITION MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Pediatric

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Adults

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Geriatric

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:CLINICAL NUTRITION MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by route of administration
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by end user
7.2.6.U.S.

7.2.6.1.U.S. market size and forecast, by route of administration
7.2.6.2.U.S. market size and forecast, by application
7.2.6.3.U.S. market size and forecast, by end user

7.2.7.Canada

7.2.7.1.Canada market size and forecast, by route of administration
7.2.7.2.Canada market size and forecast, by application
7.2.7.3.Canada market size and forecast, by end user

7.2.8.Mexico

7.2.8.1.Mexico market size and forecast, by route of administration
7.2.8.2.Mexico market size and forecast, by application
7.2.8.3.Mexico market size and forecast, by end user

7.3.Europe

7.3.1.Key trends and opportunities
7.3.2.Europe market size and forecast, by country
7.3.3.Europe market size and forecast, by route of administration
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.3.6.Germany

7.3.6.1.Germany market size and forecast, by route of administration
7.3.6.2.Germany market size and forecast, by application
7.3.6.3.Germany market size and forecast, by end user

7.3.7.UK

7.3.7.1.UK market size and forecast, by route of administration
7.3.7.2.UK market size and forecast, by application

7.3.7.3.UK market size and forecast, by end user

7.3.8.Spain

7.3.8.1.Spain market size and forecast, by route of administration
7.3.8.2.Spain market size and forecast, by application
7.3.8.3.Spain market size and forecast, by end user

7.3.9.France

7.3.9.1.France market size and forecast, by route of administration
7.3.9.2.France market size and forecast, by application
7.3.9.3.France market size and forecast, by end user

7.3.10.Italy

7.3.10.1.Italy market size and forecast, by route of administration
7.3.10.2.Italy market size and forecast, by application
7.3.10.3.Italy market size and forecast, by end user

7.3.11.Rest of Europe

7.3.11.1.Rest of Europe market size and forecast, by route of administration
7.3.11.2.Rest of Europe market size and forecast, by application

7.3.11.3.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by route of administration
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.4.6.Japan

7.4.6.1.Japan market size and forecast, by route of administration
7.4.6.2.Japan market size and forecast, by application
7.4.6.3.Japan market size and forecast, by end user

7.4.7.China

7.4.7.1.China market size and forecast, by route of administration
7.4.7.2.China market size and forecast, by application
7.4.7.3.China market size and forecast, by end user

7.4.8.India

7.4.8.1.India market size and forecast, by route of administration
7.4.8.2.India market size and forecast, by application
7.4.8.3.India market size and forecast, by end user

7.4.9.Australia

7.4.9.1.Australia market size and forecast, by route of administration
7.4.9.2.Australia market size and forecast, by application
7.4.9.3.Australia market size and forecast, by end user

7.4.10.South Korea

7.4.10.1.South Korea market size and forecast, by route of administration
7.4.10.2.South Korea market size and forecast, by application
7.4.10.3.South Korea market size and forecast, by end user

7.4.11.Rest of Asia-Pacific

7.4.11.1.Rest of Asia-Pacific market size and forecast, by route of administration
7.4.11.2.Rest of Asia-Pacific market size and forecast, by application
7.4.11.3.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by route of administration
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
7.5.6.Brazil

7.5.6.1.Brazil market size and forecast, by route of administration
7.5.6.2.Brazil market size and forecast, by application
7.5.6.3.Brazil market size and forecast, by end user

7.5.7.South Africa

7.5.7.1.South Africa market size and forecast, by route of administration
7.5.7.2.South Africa market size and forecast, by application
7.5.7.3.South Africa market size and forecast, by end user

7.5.8.Saudi Arabia

7.5.8.1.Saudi Arabia market size and forecast, by route of administration
7.5.8.2.Saudi Arabia market size and forecast, by application
7.5.8.3.Saudi Arabia market size and forecast, by end user

7.5.9.Rest of LAMEA

7.5.9.1.Rest of LAMEA market size and forecast, by route of administration
7.5.9.2.Rest of LAMEA market size and forecast, by application
7.5.9.3.Rest of LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.B. BRAUN MELSUNGEN AG

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product Portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.BAXTER INTERNATIONAL INC.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product Portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.DANONE NUTRICIA

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio

8.5.FRESENIUS SE & CO. KGAA

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.HERO NUTRITIONALS INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.LONZA LTD.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.NESTLÉ S.A.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.PERRIGO COMPANY PLC

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.PFIZER INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

LIST OF TABLES

TABLE 01.CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 02.ORAL CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 03.ENTERAL CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 04.PERENTERAL CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 05.CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 06.CANCER CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 07.NEUROLOGICAL DISEASES CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 08.GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET, BY REGION,  2020–2028 ($MILLION)
TABLE 09.METABOLIC DISORDERS CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 10.OTHERS CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 11.CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 12.PEDIATRIC CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 13.ADULT CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 14.GERIATRIC CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 15.CLINICAL NUTRITION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 16.NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 17.NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 18.NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 19.NORTH AMERICA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 20.U.S. CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 21.U.S. CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 22.U.S. CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 23.CANADA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 24.CANADA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 25.CANADA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 26.MEXICO CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 27.MEXICO CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 28.MEXICO CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 29.EUROPE CLINICAL NUTRITION MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 30.EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 31.EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 32.EUROPE CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 33.GERMANY CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 34.GERMANY CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 35.GERMANY CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 36.UK CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 37.UK CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 38.UK CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 39.SPAIN CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 40.SPAIN CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 41.SPAIN CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 42.FRANCE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 43.FRANCE CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 44.FRANCE CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 45.ITALY CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 46.ITALY CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 47.ITALY CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 48.REST OF EUROPE CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 49.REST OF EUROPE CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 50.REST OF EUROPE CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 51.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 52.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 53.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 54.ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 55.JAPAN CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 56.JAPAN CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 57.JAPAN CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 58.CHINA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 59.CHINA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 60.CHINA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 61.INDIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 62.INDIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 63.INDIA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 64.AUSTRALIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 65.AUSTRALIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 66.AUSTRALIA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 67.SOUTH KOREA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 68.SOUTH KOREA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 69.SOUTH KOREA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 73.LAMEA CLINICAL NUTRITION MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 74.LAMEA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 75.LAMEA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 76.LAMEA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 77.BRAZIL CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 78.BRAZIL CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 79.BRAZIL CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 80.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 81.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 82.SOUTH AFRICA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 83.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 84.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 85.SAUDI ARABIA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 86.REST OF LAMEA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2028 ($MILLION)
TABLE 87.REST OF LAMEA CLINICAL NUTRITION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 88.REST OF LAMEA CLINICAL NUTRITION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 89.ABBOTT: COMPANY SNAPSHOT
TABLE 90.ABBOTT: OPERATING SEGMENTS
TABLE 91.ABBOTT: PRODUCT PORTFOLIO
TABLE 92.B. BRAUN: COMPANY SNAPSHOT
TABLE 93.B. BRAUN: OPERATING SEGMENTS
TABLE 94.B. BRAUN: PRODUCT PORTFOLIO
TABLE 95.BAXTER: COMPANY SNAPSHOT
TABLE 96.BAXTER: BUSINESS SEGMENT
TABLE 97.NUTRICIA: COMPANY SNAPSHOT
TABLE 98.NUTRICIA: OPERATING SEGMENTS
TABLE 99.NUTRICIA: PRODUCT PORTFOLIO
TABLE 100.FRESENIUS: COMPANY SNAPSHOT
TABLE 101.FRESENIUS: OPERATING SEGMENTS
TABLE 102.FRESENIUS: PRODUCT PORTFOLIO
TABLE 103.HERO: COMPANY SNAPSHOT
TABLE 104.HERO: OPERATING SEGMENTS
TABLE 105.HERO: PRODUCT PORTFOLIO
TABLE 106.LONZA: COMPANY SNAPSHOT
TABLE 107.LONZA: OPERATING SEGMENTS
TABLE 108.LONZA: PRODUCT PORTFOLIO
TABLE 109.NESTLÉ: COMPANY SNAPSHOT
TABLE 110.NESTLÉ: OPERATING SEGMENTS
TABLE 111.NESTLÉ: PRODUCT PORTFOLIO
TABLE 112.PERRIGO: COMPANY SNAPSHOT
TABLE 113.PERRIGO: OPERATING SEGMENTS
TABLE 114.PERRIGO: PRODUCT PORTFOLIO
TABLE 115.PFIZER: COMPANY SNAPSHOT
TABLE 116.PFIZER: OPERATING SEGMENTS
TABLE 117.PFIZER: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.CLINICAL NUTRITION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.CLINICAL NUTRITION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 04.COMPARATIVE SHARE ANALYSIS OF ORAL CLINICAL NUTRITION MARKET, BY COUNTRY,  2020 & 2028 (%)
FIGURE 05.COMPARATIVE SHARE ANALYSIS OF ENTERAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 06.COMPARATIVE SHARE ANALYSIS OF PERENTERAL CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 07.COMPARATIVE SHARE ANALYSIS OF CANCER CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 08.COMPARATIVE SHARE ANALYSIS OF NEUROLOGICAL DISEASES CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF GASTROINTESTINAL DISEASES CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF METABOLIC DISORDERS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF OTHERS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF PEDIATRIC CLINICAL NUTRITION MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ADULT CLINICAL NUTRITION MARKET BY COUNTRY,  2020 & 2028 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF GERIATRIC CLINICAL NUTRITION MARKET BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.ABBOTT: NET SALES, 2019–2020 ($MILLION)
FIGURE 16.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 17.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 18.NET SALES, 2019–2020 ($MILLION)
FIGURE 19.B. BRAUN: NET SALES BY DIVISION, 2020 (%)
FIGURE 20.B. BRAUN: NET SALES BY REGION, 2020 (%)
FIGURE 21.NET SALES, 2019–2020 ($MILLION)
FIGURE 22.BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2020 (%)
FIGURE 23.BAXTER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 24.FRESENIUS: NET SALES, 2019–2020 ($MILLION)
FIGURE 25.FRESENIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.FRESENIUS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 27.NET SALES, 2019–2020 ($MILLION)
FIGURE 28.LONZA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.LONZA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.NET SALES, 2019–2020 ($MILLION)
FIGURE 31.NESTLÉ: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.NESTLÉ: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.PERRIGO: NET SALES, 2019–2020 ($MILLION)
FIGURE 34.PERRIGO: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.PERRIGO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36.PFIZER NET SALES, 2019–2020 ($MILLION)
FIGURE 37.PFIZER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.PFIZER: REVENUE SHARE BY GEOGRAPHY, 2020 (%)

 
 

In accordance with several interviews conducted, the clinical/medical nutrition market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry, owing to increase in prevalence of chronic disorders such as cancer and neurological disorders globally. The clinical/medical nutrition market is dominated by well-established players; hence, the market is anticipated to witness intense competition. The adoption of clinical nutrition devices and products has increased considerably, owing to increase in patient population suffering from chronic conditions along with rising number of baby boomers suffering from food ingestion, increase in unhealthy dietary habits such as growing consumption of junk food lead to scarcity of essential nutrients, which propels the market growth. In addition, increase in product approval is expected to boost the market growth in the near future.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Clinical/Medical Nutrition Market is $32,495.97 million in 2020

A. The forecast period in the report is from 2021 to 2028

A. The market value of Clinical/Medical Nutrition Market in 2020 was Million

A. The base year for the report is 2020

A. Yes, Clinical/Medical Nutrition Market companies are profiled in the report

A. The top companies that hold the market share in Clinical/Medical Nutrition Market are are Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc. and Hero Nutritionals Inc.

A. No, there is no value chain analysis provided in the Clinical/Medical Nutrition Market report

A. The key trends in the Clinical/Medical Nutrition Market are increase in cancer R&D activities and increease in pre mature birth rates

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Clinical Nutrition Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers